Since the majority of α-SYN transgenic mice do not develop a robust dopaminergic phenotype, they are less suitable to study the effect of parkin deficiency and α-synucleinopathy in nigral dopaminergic neurons [39,40]. The gene discussed is PRKN; the disease is synucleinopathy.